Table 1.

Cytopathological diagnoses (US-guided FNAC) of 93 analyzed specimens (49 patients submitted to surgery).

Cytopathological diagnoses	n	Percentage
Unsatisfactory material (Bethesda I)	2	2.1%
Negative for malignancy (Bethesda II)	37	39%
Suspected malignancy (Bethesda III–V)	44	47%
Positive for malignancy (Bethesda VI)	10	10.7%
Total	93 lobes
Histopathological diagnoses
Adenomatous goiter	43	46.2%
Follicular adenoma	2	2.1%
Hashimoto's thyroiditis	3	3.2%
Benign Hürthle cells tumor	3	3.2%
Papilliferous carcinoma	40	43%
Medullary carcinoma	2	2.1%
Total	93	100%